Evaxion Biotech (EVAX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Evaxion Biotech has announced that its board of directors is authorized to issue warrants and increase the company’s share capital until April 2029. This strategic move enables key employees and board members to acquire shares, potentially impacting the company’s financial trajectory and stock market performance.
For further insights into EVAX stock, check out TipRanks’ Stock Analysis page.